HRP20090158T1 - Supstituirani piroli, pripravci koji ih sadrže, postupak njihove pripreme i njihova upotreba - Google Patents

Supstituirani piroli, pripravci koji ih sadrže, postupak njihove pripreme i njihova upotreba

Info

Publication number
HRP20090158T1
HRP20090158T1 HR20090158T HRP20090158T HRP20090158T1 HR P20090158 T1 HRP20090158 T1 HR P20090158T1 HR 20090158 T HR20090158 T HR 20090158T HR P20090158 T HRP20090158 T HR P20090158T HR P20090158 T1 HRP20090158 T1 HR P20090158T1
Authority
HR
Croatia
Prior art keywords
substituted
pirols
procedure
preparation
independently selected
Prior art date
Application number
HR20090158T
Other languages
English (en)
Croatian (hr)
Inventor
Ronan Baptiste
Tabart Michel
Souaille Catherine
Viviani Fabrice
Bacque Eric
Lettalec Jean-Philippe
Desmazeau Pascal
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090158(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20090158T1 publication Critical patent/HRP20090158T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20090158T 2005-02-10 2006-02-08 Supstituirani piroli, pripravci koji ih sadrže, postupak njihove pripreme i njihova upotreba HRP20090158T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501354A FR2881742B1 (fr) 2005-02-10 2005-02-10 Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000286 WO2006084996A1 (fr) 2005-02-10 2006-02-08 Pyrroles substitues compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
HRP20090158T1 true HRP20090158T1 (hr) 2009-05-31

Family

ID=35478244

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090158T HRP20090158T1 (hr) 2005-02-10 2006-02-08 Supstituirani piroli, pripravci koji ih sadrže, postupak njihove pripreme i njihova upotreba

Country Status (36)

Country Link
US (1) US7592365B2 (de)
EP (1) EP1851198B1 (de)
JP (1) JP2008530061A (de)
KR (1) KR20070101317A (de)
CN (1) CN101115716A (de)
AR (1) AR052571A1 (de)
AT (1) ATE419234T1 (de)
AU (1) AU2006212106A1 (de)
BR (1) BRPI0606955A2 (de)
CA (1) CA2596822A1 (de)
CR (1) CR9231A (de)
CY (1) CY1108916T1 (de)
DE (1) DE602006004566D1 (de)
DK (1) DK1851198T3 (de)
DO (1) DOP2006000028A (de)
EA (1) EA013060B1 (de)
ES (1) ES2319926T3 (de)
FR (1) FR2881742B1 (de)
GT (1) GT200600048A (de)
HR (1) HRP20090158T1 (de)
IL (1) IL184488A0 (de)
MA (1) MA29248B1 (de)
MX (1) MX2007008789A (de)
MY (1) MY142082A (de)
NO (1) NO20074528L (de)
PA (1) PA8661601A1 (de)
PE (1) PE20061086A1 (de)
PL (1) PL1851198T3 (de)
PT (1) PT1851198E (de)
RS (1) RS50806B (de)
SI (1) SI1851198T1 (de)
TN (1) TNSN07241A1 (de)
TW (1) TW200640858A (de)
UY (1) UY29371A1 (de)
WO (1) WO2006084996A1 (de)
ZA (1) ZA200706157B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
MX2009004371A (es) 2006-10-23 2009-06-11 Lexicon Pharmaceuticals Inc Proceso para la preparacion de 5-alquil-7h-pirrolo[2,3-d]piri-midi n-2-oles.
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
WO2020034988A1 (zh) * 2018-08-14 2020-02-20 江苏豪森药业集团有限公司 凋亡信号调节激酶1抑制剂的盐及其晶型
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
ATE404550T1 (de) * 2001-09-21 2008-08-15 Smithkline Beecham Corp Chemische verbindungen
EP1436265A4 (de) 2001-09-27 2004-12-15 Smithkline Beecham Corp Chemische verbindungen
US20040138269A1 (en) * 2002-10-11 2004-07-15 Sugen, Inc. Substituted pyrroles as kinase inhibitors
GB0229581D0 (en) * 2002-12-19 2003-01-22 Cyclacel Ltd Use
US7456190B2 (en) * 2003-03-13 2008-11-25 Vertex Pharmaceuticals Incorporated Compositions useful as protein kinase inhibitors
DE10354060A1 (de) * 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation

Also Published As

Publication number Publication date
US7592365B2 (en) 2009-09-22
EA013060B1 (ru) 2010-02-26
CR9231A (es) 2007-10-23
PT1851198E (pt) 2009-03-26
PA8661601A1 (es) 2006-09-08
BRPI0606955A2 (pt) 2009-07-28
AU2006212106A1 (en) 2006-08-17
KR20070101317A (ko) 2007-10-16
MA29248B1 (fr) 2008-02-01
EP1851198B1 (de) 2008-12-31
FR2881742A1 (fr) 2006-08-11
PL1851198T3 (pl) 2009-06-30
TW200640858A (en) 2006-12-01
PE20061086A1 (es) 2006-11-30
IL184488A0 (en) 2007-10-31
CA2596822A1 (fr) 2006-08-17
GT200600048A (es) 2006-07-03
NO20074528L (no) 2007-10-31
CN101115716A (zh) 2008-01-30
UY29371A1 (es) 2006-10-02
ZA200706157B (en) 2008-11-26
CY1108916T1 (el) 2014-07-02
EA200701688A1 (ru) 2007-12-28
SI1851198T1 (sl) 2009-06-30
TNSN07241A1 (en) 2008-11-21
DOP2006000028A (es) 2006-09-15
MY142082A (en) 2010-08-30
EP1851198A1 (de) 2007-11-07
WO2006084996A1 (fr) 2006-08-17
JP2008530061A (ja) 2008-08-07
ES2319926T3 (es) 2009-05-14
MX2007008789A (es) 2007-09-11
RS50806B (sr) 2010-08-31
US20080167368A1 (en) 2008-07-10
ATE419234T1 (de) 2009-01-15
AR052571A1 (es) 2007-03-21
DK1851198T3 (da) 2009-05-04
DE602006004566D1 (de) 2009-02-12
FR2881742B1 (fr) 2007-09-07

Similar Documents

Publication Publication Date Title
HRP20080113T3 (hr) Supstituirani piridinilni i pirimidinilni derivati kao modulatori metabolizma i liječenje bolesti koje su s tim povezane
EA201591000A1 (ru) Пирролобензодиазепины
TW200612195A (en) Oxime derivatives and the use therof as latent acids
EA200702002A1 (ru) Замещённые производные пиразолилоксифенила, применяемые в качестве гербицидов
HRP20100624T8 (hr) Supstituirani pirazolo-piridini, kompozicije koje ih sadrze, postupak za njihovu pripravu, i njihova uporaba
EA200601620A1 (ru) 5,6-диалкил-7-аминотриазолопиримидины, способ их получения и их применение для борьбы с патогенными растениями, а также содержащие их средства
NO20065830L (no) Substituerte 2-kinolyloksazoler som er anvendbare som PDE4-inhibitorer.
BG98740A (en) Substituted pyrazolylpyrazoles, methods for their preparation, preparation of intermediate products and the usage of the compounds as herbicides
AR043436A1 (es) Tetrahidroisoquinolinas sustituidas para uso como moduladores 5-ht6
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
BG104248A (en) Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
AR044909A1 (es) Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia
MX2011009034A (es) Formas de profarmaco de inhibidores de cinasa y su uso en la terapia.
AR045255A1 (es) Derivados de 1,2 benzodiazol
EA201001458A1 (ru) Гербицидные соединения
CR20120302A (es) Derivados bencimidazol-imidazol
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
ME00558A (en) Pyrazole derivatives for treating hiv
ATE338461T1 (de) Pyrazolpyrimidinfungizide
MX2009011212A (es) Derivados de triazolopiridina carboxamida y triazolopirimidina carboxamida, su preparacion y su aplicacion terapeutica.
HRP20191482T1 (hr) 18f-označeni psma ciljani pet reagensi
EA201171328A1 (ru) Производное замещенного изохинолина
PA8582801A1 (es) Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa
EA201992268A1 (ru) Новые пиридазиноновые гербициды
EA200701779A1 (ru) Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии